Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$11.83 USD
-0.05 (-0.42%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $11.48 -0.35 (-2.96%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Avalo Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AVTX 11.83 -0.05(-0.42%)
Will AVTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AVTX
Is AVTX preparing to trend higher? MACD Bullish Signal Line Cross shows up after slipping 0.42%
AVTX forms Pocket Pivot on September 19
Crossed Above 20 Day Moving Average appears for AVTX after 16.09% move
Oppenheimer Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX)
AVTX: HC Wainwright & Co. Raises Price Target and Maintains Buy Rating | AVTX Stock News